Samlyn Capital, LLC Puma Biotechnology, Inc. Call Options Transaction History

Samlyn Capital, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $10.3 Million - $15 Million	-250,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$48.3 - $68.25 $12.1 Million - $17.1 Million	250,000 New	250,000 $14.8 Million
Q4 2017 Feb 14, 2018	SELL	$93.85 - $132.45 $13.8 Million - $19.5 Million	-147,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $10.6 Million - $17.6 Million	147,000	147,000 $17.6 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.